Navin Fluorine International Limited (NFIL), a leading player in India’s fluorochemicals sector, has successfully completed a qualified institutions placement (QIP) of equity shares, raising ₹7,500 million (₹750 crore).
The QIP closed on July 11, 2025, with funds raised to support NFIL’s capital expenditure and general corporate purposes as part of its long-term growth strategy.
Parties Involved
Placement Agent: JM Financial Ltd
Legal Advisor to the Issuer: Cyril Amarchand Mangaldas
Legal Advisor to Placement Agent: Not publicly disclosed
Advisory Team
Cyril Amarchand Mangaldas (CAM) advised Navin Fluorine on all legal aspects of the QIP. The transaction team included:
Yash J. Ashar – Senior Partner, Head – Capital Markets
Janhavi Manohar – Partner
Rushab Dhandokia – Principal Associate
Ankesh Kumar – Senior Associate
Harsha Menon – Associate
Prakhar Jain– Associate
Jayadeep Manchikalapudi– Associate
The team provided end-to-end legal advisory including offer structuring, due diligence, drafting of offer documents, regulatory filings, and execution support.
Key Transaction Highlights
₹750 crore raised via a QIP route by issuing equity shares to qualified institutional buyers (QIBs).
The QIP issuance was structured to maintain regulatory compliance under SEBI (ICDR) Regulations, 2018.
Proceeds will primarily be used for strategic expansions, including manufacturing enhancements and R&D initiatives in high-value fluorinated compounds.
About Navin Fluorine International Ltd.
NFIL operates one of India’s largest fluorination facilities and is a key global supplier of fluorine-based acids and gases, catering to industries such as pharmaceuticals, agrochemicals, and refrigeration.
Headquartered in Mumbai, NFIL has steadily expanded its R&D-led chemical manufacturing footprint with a focus on high-performance specialty fluorochemicals.
Strategic Significance
The QIP proceeds are expected to support Navin Fluorine’s ongoing capex and innovation pipeline, particularly in high-value fluorine derivatives, positioning the company for global scale and export-led growth.
This also reinforces the company’s capital structure, strengthens its balance sheet, and supports long-term business resilience.
Why It Matters
QIPs remain a preferred fundraising tool for listed companies seeking capital without undergoing a full IPO process.
The deal underscores strong institutional investor confidence in the chemicals and specialty materials sector.
From a legal perspective, it highlights the growing regulatory and transactional sophistication in mid-cap QIP issuances in India.
As Navin Fluorine scales operations to meet global demand for specialty fluorochemicals, the ₹750 crore QIP signals both investor confidence and sectoral momentum.
For more legal deal updates and analysis, stay tuned to TheCourtroom.in
Disclaimer
This article is for informational purposes only and does not constitute legal or financial advice. Readers should consult professionals before making decisions.
